CA2378472A1 - Procede et composition permettant d'affecter les systemes de reproduction - Google Patents

Procede et composition permettant d'affecter les systemes de reproduction Download PDF

Info

Publication number
CA2378472A1
CA2378472A1 CA002378472A CA2378472A CA2378472A1 CA 2378472 A1 CA2378472 A1 CA 2378472A1 CA 002378472 A CA002378472 A CA 002378472A CA 2378472 A CA2378472 A CA 2378472A CA 2378472 A1 CA2378472 A1 CA 2378472A1
Authority
CA
Canada
Prior art keywords
zona pellucida
protein
pellucida protein
organism
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002378472A
Other languages
English (en)
Inventor
Richard Fayrer-Hosken
Branson W. Ritchie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc UGARF
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2378472A1 publication Critical patent/CA2378472A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne une composition immunogénique comprenant un immunogène, dérivé d'une protéine de la zone pellucide, et permettant de commander la reproduction animale, de traiter les maladies et troubles de la reproduction, ainsi que de gérer le comportement animal.
CA002378472A 1999-07-01 2000-06-30 Procede et composition permettant d'affecter les systemes de reproduction Abandoned CA2378472A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14230899P 1999-07-01 1999-07-01
US60/142,308 1999-07-01
US17790300P 2000-01-25 2000-01-25
US60/177,903 2000-01-25
PCT/US2000/018249 WO2001002000A2 (fr) 1999-07-01 2000-06-30 Procede et composition permettant d'affecter les systemes de reproduction

Publications (1)

Publication Number Publication Date
CA2378472A1 true CA2378472A1 (fr) 2001-01-11

Family

ID=26839964

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002378472A Abandoned CA2378472A1 (fr) 1999-07-01 2000-06-30 Procede et composition permettant d'affecter les systemes de reproduction

Country Status (3)

Country Link
AU (1) AU5909500A (fr)
CA (1) CA2378472A1 (fr)
WO (1) WO2001002000A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1297745B1 (fr) 2001-09-26 2007-11-14 Ovagen International Ltd. Procédé de production d'oeufs de volaille et d'oiseaux avec une spécificité de "non-contamination"
CN101365473B (zh) 2005-11-16 2013-04-03 潘塔希生物科学股份有限公司 用于治疗或预防卵巢癌的药物组合物
CA2643220A1 (fr) 2006-02-23 2007-08-30 Leonard Moran Procede d'incubation et d'eclosion d'oeufs
WO2007096418A1 (fr) * 2006-02-23 2007-08-30 Ovagen International Limited Procédés améliorés de production d'oeufs aviaires et d'oiseaux présentant un état spécifié exempt de germes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9094191A (en) * 1990-11-21 1992-06-25 Washington University Recombinant avirulent salmonella antifertility vaccines
WO1993025231A1 (fr) * 1992-06-05 1993-12-23 Dalhousie University Utilisation de glycoproteines de la zone pellucide dans l'immunocontraception
CA2356452A1 (fr) * 1998-12-22 2000-06-29 Robert Brown Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux

Also Published As

Publication number Publication date
WO2001002000A9 (fr) 2002-08-01
WO2001002000A3 (fr) 2002-05-10
WO2001002000A2 (fr) 2001-01-11
AU5909500A (en) 2001-01-22

Similar Documents

Publication Publication Date Title
US9579379B1 (en) Saponin adjuvant compositions and methods relating thereto
DE60117164T2 (de) Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
Bradley Experimental strategies for the development of an immunocontraceptive vaccine for the European red fox, Vulpes vulpes
CA2513744C (fr) Depletion de cellules germinales embryonnaires endogenes dans des espaces aviaires
JP5231378B2 (ja) 免疫原性ｌｈｒｈ組成物およびそれに関する方法
EA005248B1 (ru) Способ отрицательной регуляции активности gdf-8
KR20080113217A (ko) 조류 인플루엔자 바이러스에 대한 키메릭 백신 항원
RU2501565C2 (ru) Слитый белок дефектная хлорамфеникол ацетилтрансфераза (сат)-соматостатин и его применения
US5807551A (en) Method to provide artificial passive immunity in birds
JP6310389B2 (ja) ワクチン
CA2378472A1 (fr) Procede et composition permettant d'affecter les systemes de reproduction
JP2018512152A (ja) 鳥類ワクチン
US5736141A (en) Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
Manzano-Román et al. Antigens from the midgut membranes of Ornithodoros erraticus induce lethal anti-tick immune responses in pigs and mice
WO2000037100A2 (fr) Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux
USRE37224E1 (en) Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
WO1993025231A1 (fr) Utilisation de glycoproteines de la zone pellucide dans l'immunocontraception
TWI227114B (en) Oral vaccine for aquatic animals
US7807144B2 (en) Oral vaccines
CA2378478A1 (fr) Vaccin anti-fecondite contenant une proteine de membrane pellucide aviaire et procede d'utilisation
Miller Delivery of immunocontraceptive vaccines for wildlife management
WO1999034825A1 (fr) Vaccin anti-fecondite et mode d'utilisation
Lo et al. Current ZP3-based immunocontraceptive vaccine for free ranging wild pest.
JP4925236B2 (ja) マダニセメントタンパク質を含むワクチン
US20030171283A1 (en) Inhibin compositions and methods of enhancing production performance

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead